Table 3.

Efficacy of lncRNAs or circRNAs in the differential diagnosis of pancreatic cancer from healthy participants

Study	Markers	source	Diagnostic power
			AUC	Sensitivity (%)	Specificity (%)
lncRNAs
Guo et al	SNHG15	Serum	0.727	68.3	89.6
Li et al	Linc-pint	Plasma	0.87	87.5	77.1
	Linc-pint + CA19-9	Plasma	0.92	85.9	82.9
circRNAs
Yang et al	circ-LDLRAD3 + CA19-9	plasma	0.87	80.33	93.55